You may have heard about The Future of PrEP is Now, a research project aimed at understanding the needs and preferences of Two-Spirit, gay, bisexual, trans and queer (2SGBTQ) men and non-binary folks in regards to long-acting HIV pre-exposure prophylaxis (PrEP) delivery. Despite the fact that oral PrEP is very effective at preventing HIV, it remains underprescribed to many equity-seeking communities.
The waniska Indigenous Centre for HIV, hepatitis C (HCV) and sexually transmitted blood-borne illness (STBBI), funded by the Canadian Institutes of Health Research and based at the University of Saskatchewan, is going to undertake research in a new way. It will engage Indigenous communities and people in research that is focused on Indigenous knowledge and the land to develop, explore and scale up promising and wise practices using both an Indigenous and Western lens.
Viral hepatitis impacts Indigenous peoples around the world at much higher than average rates, harming their physical, spiritual, emotional, social and economic health. This is the result of historic and ongoing colonialism, and includes significantly worse health determinants, inadequate access to immunization and treatment, and inadequacies in the provision of culturally safe and responsive healthcare to Indigenous people. COVID-19 has further impacted Indigenous peoples, but many communities and healthcare practitioners are finding innovative ways of responding to the pandemic, while simultaneously trying to continue providing hepatitis care. Many of these responses were shared in a virtual mini-conference hosted by the...
An introduction by Dr. Jordan Feld, University Health Network Nearly 250,000 Canadians are living with hepatitis C (HCV), yet 45% are undiagnosed and remain at risk of developing complications related to long-term liver damage like liver cancer. Hepatitis C causes more years of life lost than any other infectious disease in Canada. Fortunately, with the arrival of safe treatment that cures more than 95% of people, combined with simple diagnostic methods and effective prevention strategies, we now have the tools to eliminate hepatitis C.
Why do First Nations, Métis and Inuit in Canada carry such an unfair burden of hepatitis C in Canada? It is estimated that hepatitis C among Indigenous people is five-times higher than non-Indigenous Canadians. In particular, Indigenous women represent almost half of all hepatitis C cases in their communities, a much higher proportion than among the non-Indigenous Canadian population. Young Indigenous people (24 years and under) represent 70% to 80% of hepatitis C infections among people who inject drugs in Canada.
Saskatchewan has led the country in the rate of new HIV infections and the proportion of people living with HIV since 2009. The HIV epidemic in this province is unique from other jurisdictions in Canada in that more than three-quarters of our new infections occur in people who use injection drugs (the Canadian average is less than 14%).
